Sotagliflozin Shows Promise in Improving Glycemic Control for Patients with Type 1 Diabetes and Chronic Kidney Disease
Lexicon Pharmaceuticals, Inc. revealed groundbreaking findings from a recent post hoc analysis of the inTandem3 study on March 12, 2024. ...
